Article Versions Notes

Laversin A, Dufossez R, Bolteau R, Duroux R, Ravez S, Hernandez-Tapia S, Fossart M, Coevoet M, Liberelle M, Yous S, et al. Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists. Molecules. 2024; 29(16):3847. https://doi.org/10.3390/molecules29163847

Laversin, Amélie, Robin Dufossez, Raphaël Bolteau, Romain Duroux, Séverine Ravez, Sergio Hernandez-Tapia, Martin Fossart, Mathilde Coevoet, Maxime Liberelle, Saïd Yous, and et al. 2024. "Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists" Molecules 29, no. 16: 3847. https://doi.org/10.3390/molecules29163847

Laversin, A., Dufossez, R., Bolteau, R., Duroux, R., Ravez, S., Hernandez-Tapia, S., Fossart, M., Coevoet, M., Liberelle, M., Yous, S., Lebègue, N., & Melnyk, P. (2024). Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists. Molecules, 29(16), 3847. https://doi.org/10.3390/molecules29163847